Found vs SynergyRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

SynergyRx beats Found overall, scoring 7.6/10 vs 7.3/10. Found is more affordable at $129/mo vs $199/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose SynergyRx for needle-phobic users who want oral dissolving tablets for sem.

A side-by-side look at Found and SynergyRx to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Found

#36 of 52

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

SynergyRx

#22 of 52

7.6/10

Bundled GLP-1 program with predictable pricing and round-the-clock support access for peace of mind.

Visit SynergyRx

Feature	Found	SynergyRx
Our Score	7.3/10	7.6/10
Starting Price	$129/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	Yes	No
Best For	Insured patients who want their GLP-1 coverage checked and their copay minimized	Needle-phobic users who want oral dissolving tablets for semaglutide or tirzepatide, with 24/7 support included
Ranking	#36	#22
Get started	Visit Found	Visit SynergyRx

Pros & Cons Compared

Found

Pros

+Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
−The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
−Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

SynergyRx

Pros

+Oral dissolving tablets for BOTH semaglutide AND tirzepatide, one of the few platforms with needle-free tirzepatide
+Free expedited shipping included with all orders
+24/7 support with unlimited messaging, no per-visit fees for follow-up questions or dose adjustments
+Both compounded and brand-name options available (Ozempic, Wegovy, Mounjaro)

Cons

−Registered at a Casper, WY address with limited independent reviews. Verify pharmacy partners and provider credentials before enrolling.
−Brand-name pricing ($499-947/mo) is very high compared to direct manufacturer programs like LillyDirect. Use SynergyRx for its compounded oral tablets; source brand-name directly if that's what you need.
−Company history, founding date, and ownership structure are not publicly disclosed. Ask support for pharmacy and prescriber details upfront.

Our Verdict

SynergyRx edges out Found with a score of 7.6/10 vs 7.3/10. If budget is your priority, Found starts at $129/mo compared to SynergyRx's $199/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose SynergyRx if you want: needle-phobic users who want oral dissolving tablets for semaglutide or tirzepatide, with 24/7 support included.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Found nor SynergyRx feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review